Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

2.
3.

Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.

Williams MD, Roberts D, Blumenschein GR Jr, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK.

Am J Surg Pathol. 2007 Nov;31(11):1645-52.

PMID:
18059220
4.

Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma.

Hoang MP, Callender DL, Sola Gallego JJ, Huang Z, Sneige N, Luna MA, Batsakis JG, El-Naggar AK.

Int J Oncol. 2001 Oct;19(4):865-71.

PMID:
11562768
5.

Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.

Nagao T, Gaffey TA, Visscher DW, Kay PA, Minato H, Serizawa H, Lewis JE.

Am J Surg Pathol. 2004 Mar;28(3):319-26.

PMID:
15104294
6.

Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor alpha in salivary duct carcinoma.

Fan CY, Melhem MF, Hosal AS, Grandis JR, Barnes EL.

Arch Otolaryngol Head Neck Surg. 2001 Sep;127(9):1075-9.

PMID:
11556855
7.

Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis.

Moriki T, Ueta S, Takahashi T, Mitani M, Ichien M.

Cancer. 2001 Oct 25;93(5):344-50.

PMID:
11668470
8.

[Salivary duct carcinomas comprise phenotypically and genotypically diverse high grade neoplasms].

Hungermann D, Korsching E, Bürger H, Röser K, Löning T, Herbst H.

Verh Dtsch Ges Pathol. 2006;90:168-76. German.

PMID:
17867594
9.

Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases.

Simpson RH, Prasad AR, Lewis JE, Skálová A, David L.

Am J Surg Pathol. 2003 Aug;27(8):1070-9.

PMID:
12883239
10.

Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.

Yamamoto H, Uryu H, Segawa Y, Tsuneyoshi M.

Pathol Int. 2008 May;58(5):322-6. doi: 10.1111/j.1440-1827.2008.02231.x.

PMID:
18429833
11.

Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature.

Nagao T, Gaffey TA, Serizawa H, Iwaya K, Watanabe A, Yoshida T, Yamazaki K, Sageshima M, Lewis JE.

Am J Clin Pathol. 2004 Aug;122(2):222-31.

12.

Localization of prostate-specific antigen-like immunoreactivity in human salivary gland and salivary gland tumors.

Tazawa K, Kurihara Y, Kamoshida S, Tsukada K, Tsutsumi Y.

Pathol Int. 1999 Jun;49(6):500-5.

PMID:
10469392
13.

Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.

Yang M, Moriya T, Oguma M, De La Cruz C, Endoh M, Ishida T, Hirakawa H, Orita Y, Ohuchi N, Sasano H.

Pathol Int. 2003 Jul;53(7):422-8.

PMID:
12828606
14.

Salivary duct carcinoma cytologically diagnosed distinctly from salivary gland carcinomas with squamous differentiation.

Kawahara A, Harada H, Akiba J, Kage M.

Diagn Cytopathol. 2008 Jul;36(7):485-93. doi: 10.1002/dc.20823.

PMID:
18528886
15.
18.

Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study.

Oxley JD, Abbott CD, Gillatt DA, MacIver AG.

Br J Urol. 1998 Jan;81(1):109-15.

PMID:
9467486
19.
20.

Aspiration and imprint cytopathology of salivary duct carcinoma.

Domson KK, Wakely PE Jr.

Cancer. 1997 Oct 25;81(5):281-6.

PMID:
9349515
Items per page

Supplemental Content

Write to the Help Desk